Literature DB >> 15817957

Neuropathology of HIV/AIDS with an overview of the Indian scene.

S K Shankar1, Anita Mahadevan, P Satishchandra, R Uday Kumar, T C Yasha, Vani Santosh, A Chandramuki, V Ravi, Avindra Nath.   

Abstract

Neurological manifestations of HIV infection and AIDS are being recognized with a frequency that parallels the increasing number of AIDS cases. Next to sub-Saharan Africa, India has the second largest burden of HIV related pathology, essentially caused by HIV-1 clade C in both the geographic locales, in contrast to USA and Europe. But the true prevalence of HIV related neuroinfections and pathology is not available due to inadequate medical facilities, social stigma and ignorance that lead to underdiagnosis. Neurotuberculosis, followed by cryptococcosis and toxoplasmosis in various combinations are the major neuropathologies reflecting the endemicity and manifesting clinically by reactivation of latent infection. Discordance in the clinical prevalence of various infections, when compared to pathological studies highlight similarities in clinical, radiological modalities of diagnosis and inherent problems in establishing definitive diagnosis. Viral infections appear to be relatively rare. Inspite of heavy burden of HIV/AIDS, HIV associated neoplasia is infrequent, including primary CNS lymphomas. HIV encephalitis and HIV associated dementia are considered infrequent, though systematic studies have just been initiated in various centres. Peripheral neuropathy characteristically manifests with vasculitic neuropathy while diffuse infiltrative lymphocytosis syndrome (DILS) involving nerves has not been reported from India. Spinal cord pathology including vacuolar myelopathy is rare, even in asymptomatic cases. Till now the AIDS cases in India were drug naive but a new cohort of cases following initiation of HAART therapy as a national policy is soon emerging, altering the biology and evolution of HIV/AIDS in India. Lacunae in the epidemiology, diagnosis and study of biology of HIV/AIDS are outlined for future research.

Entities:  

Mesh:

Year:  2005        PMID: 15817957

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  21 in total

1.  Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins.

Authors:  Grant R Campbell; Jennifer D Watkins; Erwann P Loret; Stephen A Spector
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-07       Impact factor: 2.205

Review 2.  Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?

Authors:  Heather Carryl; Melanie Swang; Jerome Lawrence; Kimberly Curtis; Herman Kamboj; Koen K A Van Rompay; Kristina De Paris; Mark W Burke
Journal:  ACS Chem Neurosci       Date:  2015-06-19       Impact factor: 4.418

3.  Genetic diversity and proviral DNA load in different neural compartments of HIV-1 subtype C infection.

Authors:  Mamata Mishra; Rebu K Varghese; Anjali Verma; Sutanuka Das; Renato Santana Aguiar; Amilcar Tanuri; Anita Mahadevan; Susarla K Shankar; Parthasarathy Satishchandra; Udaykumar Ranga
Journal:  J Neurovirol       Date:  2015-03-07       Impact factor: 2.643

4.  Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes.

Authors:  Grant R Campbell; Jennifer D Watkins; Kumud K Singh; Erwann P Loret; Stephen A Spector
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function.

Authors:  Myres W Tilghman; Jayanta Bhattacharya; Suprit Deshpande; Manisha Ghate; Stephen Espitia; Igor Grant; Thomas D Marcotte; Davey Smith; Sanjay Mehendale
Journal:  J Med Virol       Date:  2013-10-22       Impact factor: 2.327

6.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

7.  Neuropathological correlate of the "concentric target sign" in MRI of HIV-associated cerebral toxoplasmosis.

Authors:  Anita Mahadevan; Arvinda Hanumantapura Ramalingaiah; Satishchandra Parthasarathy; Avindra Nath; Udaykumar Ranga; Shankar Susarla Krishna
Journal:  J Magn Reson Imaging       Date:  2013-02-25       Impact factor: 4.813

8.  Successful treatment of cerebral toxoplasmosis with clindamycin: a case report.

Authors:  Deepak Madi; Basavaprabhu Achappa; Satish Rao; John T Ramapuram; Soundarya Mahalingam
Journal:  Oman Med J       Date:  2012-09

9.  Usefulness of stereotactic biopsy and neuroimaging in management of HIV-1 Clade C associated focal brain lesions with special focus on cerebral toxoplasmosis.

Authors:  C Shyam babu; P Satishchandra; A Mahadevan; V Pillai Shibu; S Ravishankar; N Sidappa; R Udaykumar; V Ravi; S K Shankar
Journal:  Clin Neurol Neurosurg       Date:  2012-11-12       Impact factor: 1.876

10.  NeuroAIDS in the Asia Pacific Region.

Authors:  Edwina J Wright; Michael Nunn; Jeymohan Joseph; Kevin Robertson; Luxshimi Lal; Bruce J Brew
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.